Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: Apoptosis, cell proliferation, and inflammatory activity

Infection and Immunity

Volumn 69, Issue 8, 2001, Pages 5056-5063

  Tae Il Kim, ^a   Yong Chan Lee, ^a   Kwang Hyoung Lee, ^a   Jae Ho Han, ^a   Chae Yoon Chon, ^a   Young Myoung Moon, ^a   Jin Kyung Kang, ^a   In Suh Park, ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; KI 67 ANTIGEN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EPITHELIUM CELL; FEMALE; HELICOBACTER PYLORI; INFLAMMATION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH MUCOSA; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELL DIVISION; CHRONIC DISEASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES;

EID: 0034916387     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.8.5056-5063.2001     Document Type: Article

References (66)

1. Helicobacter pylori and risk of ulcer bleeding among users of non-steroidal anti-inflammatory drugs: A case-control study
2. Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis
3. Helicobacter pylori induces cyclooxygenase-1 as well as cyclooxygenase-2 in endothelial cells
4. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
5. Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of Bak
6. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1
7. Carcinogenesis, apoptosis and cell proliferation
8. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines
9. Classification and grading of gastritis
10. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
11. Systemic mediators of inflammation
12. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation
13. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
14. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation
15. Gastric adaptation: Studies in humans during continuous aspirin administration
16. Prevention of nonsteroidal antiinflammatory drug-induced gastric ulceration with misoprostol: Multicenter, double blind, placebo-controlled trial
17. Incidence of cancer among patients with rheumatoid arthritis
18. Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance
19. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study
20. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis
21. Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa
22. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
23. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection
24. Helicobacter pylori infection and the development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy
25. Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans
26. Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin
27. A randomised trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
28. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain
29. Interaction of Helicobacter pylori eradication and non-steroidal anti-inflammatory drugs on gastric epithelial apoptosis and proliferation: Implications on ulcerogenesis
30. Aspirin use in patients with major gastrointestinal bleeding and peptic ulceration
31. Effects of nonsteroidal anti-inflammatory drugs and misoprostal on gastroduodenal epithelial proliferation in arthritis
32. Free radicals: Their involvement in disease processes
33. Helicobacter pylori, gastric cancer and gastric epithelial kinetics: A review
34. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants
35. Apoptosis and the cell cycle
36. Nitric oxide as a mediator of inflammation? - You had better believe it
37. Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice
38. Cellular markers in the gastric precancerous process
39. Induction of gastric epithelial apoptosis by Helicobacter pylori
40. Helicobacter pylori infection and the risk of gastric carcinoma
41. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in mongolian gerbils
42. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis
43. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
44. Cell death by apoptosis: Basic concepts and disease relevance for the gastroenterologist
45. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: Role of VacA and CagA
46. 2 synthesis in MKN 28 gastric mucosal cells in vitro
47. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis
48. Do nonsteroidal anti-inflammatory drugs have an effect on gastric cell turnover?
49. Cyclooxygenase-2 inhibitors suppress the growth of gastric xenografts via induction of apoptosis in nude mice
50. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro
51. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
52. Role of cyclooxygenase-2 in the healing of gastric ulcers in rats
53. The development of the endothelin-1-induced gastric ulcer: Time sequence analysis of morphologic changes
54. Inhibition of cyclooxygenase: A novel approach to cancer prevention
55. The effects of nonsteroidal anti-inflammatory drugs on immune functions of human peripheral blood mononuclear cells
56. An international association between Helicobacter pylori infection and gastric cancer
57. Aspirin use and risk of fatal cancer
58. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
59. Regulation of gastric epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis
60. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
61. NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2
62. Chemopreventive effects of NSAIDs against colorectal cancer: Regulation of apoptosis and mitosis by COX-1 and COX-2
63. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis
64. Gastroduodenal toxicity of nonsteroidal antiinflammatory drugs
65. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis
66. Nonsteroidal antiinflmmatory drugs could reverse Helicobacter pylori-induced apoptosis and proliferation in gastric epithelial cells